ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,727.60
-1.08%
S&P ASX All Technology
3,063.80
-1.27%
Brent Oil
81.965
0.00%
US Dollar vs AUD
1.50943
0.00%
Bitcoin
69,078.58
-0.27%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Marker Therapeutics (delisted) (TPIV)

  7. Marker Therapeutics (delisted) (TPIV) News

TPIV

TapImmune, Inc. (TPIV)

Marker Therapeutics (delisted)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TPIV
DateTimeSourceHeadlineSymbolCompany
20/10/201808:10Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:TPIVMarker Therapeutics (delisted)
20/10/201807:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
20/10/201807:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
20/10/201807:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
20/10/201807:33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
20/10/201807:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:50Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:50Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201807:49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201807:02Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201807:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201802:45PR Newswire (US)TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And FinancingNASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201823:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201823:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201823:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201823:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201823:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
11/10/201807:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
10/10/201821:30PR Newswire (US)TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded b...NASDAQ:TPIVMarker Therapeutics (delisted)
26/09/201807:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
 Showing the most relevant articles for your search:NASDAQ:TPIV

Your Recent History

ASX
MQG
Macquarie
FX
AUDJPY
AUD vs Yen
NASDAQ
TSLA
Tesla
FX
GBPAUD
Sterling vs AUD
ASX
WES
Wesfarmers
NASDAQ
NVDA
NVIDIA
ASX
WBC
Westpac Banking
ASX
SUN
Suncorp
NYSE
KO
Coca Cola
ASX
NAB
National Australia Bank
NYSE
VZ
Verizon Communications
NASDAQ
GOOGL
Alphabet
ASX
ANZ
Australia And New Zealan...
ASX
CSL
CSL
ASX
WPL
Woodside Petroleum
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved